Pacira BioSciences, Inc. PCRX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s net change in cash?
- Pacira BioSciences, Inc. (PCRX) reported net change in cash of -$14.24M in Q1 2026.
- How has Pacira BioSciences, Inc.'s net change in cash changed year-over-year?
- Pacira BioSciences, Inc.'s net change in cash decreased by 308.3% year-over-year, from $6.84M to -$14.24M.
- What is the long-term trend for Pacira BioSciences, Inc.'s net change in cash?
- Over 3 years (2021 to 2025), Pacira BioSciences, Inc.'s net change in cash has grown at a -35.7% compound annual growth rate (CAGR), from $485.62M to -$129.19M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.